Background and Purpose: Cerebral syncope refers to a loss of consciousness associated with cerebral vasoconstriction in the absence of systemic hypotension. The diagnosis of cerebral syncope could be established by the head-up tilt test (HUT) and transcranial Doppler ultrasonography. Valsalva maneuver (VM) permitted assessment of cerebral autoregulatory function by provoking blood pressure (BP) changes. To develop a path-physiological approach for vasomotor reactivity of cerebral syncope, the authors combined these maneuvers (HUT/transcranial Doppler/VM). Methods: Using transcranial Doppler ultrasonography, we simultaneously recorded systemic arterial BP in the radial artery and flow velocities in both middle cerebral arteries (MCAFV) in 10 cerebral syncope patients (4 males and 6 females, 35.24 ± 4.5 years old) during the Valsalva maneuver. Results: The characteristic changes in BP (phases I–IV) were seen in all subjects, accompanying distinct changes in cerebral blood flow velocity. The BP/heart rate responding to VM was within normal limit in all subjects. There was no orthostatic hypotension. Instead, BP increased during the tilting test in 2 subjects (20.00%). The MCAFV dropped 25.4 ± 2.3% from baseline. Abnormal flattening of MCAFV during late phase II (IIb), the paradoxical drop of flow velocity despite restoration of BP, was noted in 9 subjects (90.00%). Conclusion: During VM there are complex changes in relevant cardiovascular and cerebrovascular variables within a short time span. The paradoxical drop of MCAFV during phase IIb was the result of complex parameters. Among them, a failure in cerebrovascular resistance reduction and even paradoxical vasoconstriction might further compromise cerebral perfusion pressure and lead to syncope.

Keywords:
Cerebral syncope, Valsalva maneuver, Head-up tilt test, Transcranial Doppler, Autoregulation
1.
Grubb BP: Cerebral syncope: new insights into an emerging entity. J Pediatr 2000;13:431–432.
2.
Grubb BP, Samoil D, Kosinski D, Wolfe D, Brewster P, Elliott L, Hahn H: Cerebral syncope: loss of consciousness associated with cerebral vasoconstriction in the absence of systemic hypotension. Pacing Clin Electrophysiol 1998;21:652–658.
3.
Rodriguez-Nunez A, Fernandez-Cebrian S, Perez-Munuzuri A, Martinon-Torres F, Eiris-Punal J, Martinon-Sanchez JM: Cerebral syncope in children. J Pediatr 2000;136:542–544.
4.
Bisharat N, Paz E, Klimov A, Friedberg N, Elias M: Cerebral syncope in a patient with spinal cord injury. Pacing Clin Electrophysiol 2002;25:372–373.
5.
Zhang R, Crandall CG, Levine BD: Cerebral hemodynamics during the Valsalva maneuver: insights from ganglionic blockade. Stroke 2004;35:843–847.
6.
Smith ML, Beightol LA, Fritsch-Yelle JM, Ellenbogen KA, Porter TR, Eckberg DL: Valsalva’s maneuver revisited: a quantitative method yielding insights into human autonomic control. Am J Physiol 1996;271:1240–1249.
7.
Hathaway DK, Cashion AK, Wicks MN, Milstead EJ, Gaber AO: Cardiovascular dysautonomia of patients with end-stage renal disease and type I or type II diabetes. Nurs Res 1998;47:171–179.
8.
Sandroni P, Novak V, Opfer-Gehrking TL, Huck CA, Low PA: Mechanisms of blood pressure alterations in response to the Valsalva maneuver in postural tachycardia syndrome. Clin Auton Res 2000;10:1–5.
9.
Grubb BP, Karas B, Kosinski D, Boehm K: Preliminary observations on the use of midodrine hydrochloride in the treatment of refractory neurocardiogenic syncope. J Interv Card Electrophysiol 1999;3:139–143.
10.
Davenport A, Will EJ, Davison AM: Effect of posture on intracranial pressure and cerebral perfusion pressure in patients with fulminant hepatic and renal failure after acetaminophen self-poisoning. Crit Care Med 1990;18:286–289.
11.
Oshita M, Kigoshi S, Muramatsu I: Contractile action of yohimbine in the dog basilar artery. Blood Vessels 1985;22:257–264.
12.
Willems EW, Valdivia LF, Villalon CM, Saxena PR: Possible role of alpha-adrenoceptor subtypes in acute migraine therapy. Cephalalgia 2003;23:245–257.
13.
Kimmerly DS, Tutungi E, Wilson TD, Serrador JM, Gelb AW, Hughson RL, Shoemaker JK: Circulating norepinephrine and cerebrovascular control in conscious humans. Clin Physiol Funct Imaging 2003;23:314–319.
© 2005 S. Karger AG, Basel
2005
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.